E
77.92
-0.28 (-0.36%)
| Penutupan Terdahulu | 78.20 |
| Buka | 77.49 |
| Jumlah Dagangan | 1,693,543 |
| Purata Dagangan (3B) | 4,890,374 |
| Modal Pasaran | 45,707,870,208 |
| Harga / Pendapatan (P/E TTM) | 32.20 |
| Harga / Pendapatan (P/E Ke hadapan) | 31.06 |
| Harga / Jualan (P/S) | 8.18 |
| Harga / Buku (P/B) | 4.40 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Jul 2025 - 28 Jul 2025 |
| Margin Keuntungan | 75.71% |
| Margin Operasi (TTM) | 29.01% |
| EPS Cair (TTM) | 2.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.86% |
| Nisbah Semasa (MRQ) | 4.45 |
| Aliran Tunai Operasi (OCF TTM) | 876.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
| Pulangan Atas Aset (ROA TTM) | 8.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Edwards Lifesciences Corporatio | Menaik | Menurun |
AISkor Stockmoo
-2.1
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | -5.0 |
| Osilator Teknikal | -1.5 |
| Purata | -2.10 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.92% |
| % Dimiliki oleh Institusi | 89.58% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 95.00 (Citigroup, 21.92%) | Beli |
| Median | 75.00 (-3.75%) | |
| Rendah | 75.00 (Canaccord Genuity, -3.75%) | Pegang |
| 75.00 (Baird, -3.75%) | Pegang | |
| 75.00 (Truist Securities, -3.75%) | Pegang | |
| Purata | 80.60 (3.44%) | |
| Jumlah | 2 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 74.17 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 22 May 2025 | 95.00 (21.92%) | Beli | 74.79 |
| Piper Sandler | 13 May 2025 | 83.00 (6.52%) | Beli | 75.50 |
| 24 Apr 2025 | 80.00 (2.67%) | Beli | 75.13 | |
| Canaccord Genuity | 25 Apr 2025 | 75.00 (-3.75%) | Pegang | 76.04 |
| Baird | 24 Apr 2025 | 75.00 (-3.75%) | Pegang | 75.13 |
| Truist Securities | 11 Apr 2025 | 75.00 (-3.75%) | Pegang | 69.40 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ZOVIGHIAN BERNARD J | - | 77.72 | -967 | -75,155 |
| Jumlah Keseluruhan Kuantiti Bersih | -967 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -75,155 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 77.72 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ZOVIGHIAN BERNARD J | Pegawai | 03 Jun 2025 | Jual automatik (-) | 967 | 77.72 | 75,155 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 May 2025 | Pengumuman | Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes |
| 06 May 2025 | Pengumuman | Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference |
| 01 May 2025 | Pengumuman | Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis |
| 23 Apr 2025 | Pengumuman | Edwards Lifesciences Reports First Quarter Results |
| 18 Apr 2025 | Pengumuman | Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue |
| 16 Apr 2025 | Pengumuman | Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025 |
| 14 Apr 2025 | Pengumuman | Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System |
| 31 Mar 2025 | Pengumuman | New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |